Riskpilot← Back to searchSign inGet full accessJELSTAD SANDANGER AS
ASActiveOrg 997334922Lysthusbråten 45, 1383 AskerMedical specialists activities · NACE 8622Est. 20111 employees
Revenue 2024
NOK 0
EBITDA margin
—
-126% vs 2023
Equity ratio
91.5%
Financial strength
Net profit 2024
NOK -490K
-113% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -1,2M | -126% |
| Net profit | NOK -490K | -113% |
| Total assets | NOK 4,4M | -28% |
| Equity | NOK 4M | -11% |
| Employees | 1 | — |
Legal name
JELSTAD SANDANGER AS
Org number
997334922
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. september 2011
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Spesialistlegepraksis i gastroenterologi. Investering i verdipapirer, samt hva hermed står i forbindelse.
Address
Lysthusbråten 45, 1383 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 528 | 7 028 | 7 617 | 7 221 | 0 |
| Staff expenses | −1 741 | −1 910 | −1 967 | −1 438 | −1 054 |
| EBITDA | 3 097 | 3 644 | 3 926 | 4 597 | −1 204 |
| Depreciation & amort. | −301 | −320 | −288 | −0 | −0 |
| EBIT | 2 797 | 3 324 | 3 638 | 4 597 | −1 204 |
| Net financials | 20 | 7 | 17 | 178 | 477 |
| Profit before tax | 2 817 | 3 331 | 3 655 | 4 775 | −728 |
| Tax | 613 | 704 | 789 | 889 | −237 |
| Net profit | 2 204 | 2 627 | 2 866 | 3 885 | −490 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 156 | 4 953 | 5 021 | 6 152 | 4 400 |
| Equity | 1 640 | 1 266 | 2 633 | 4 518 | 4 027 |
| Long-term debt | 0 | 0 | 0 | 390 | 152 |
| Short-term debt | 2 516 | 3 686 | 2 389 | 1 244 | 221 |
| Total debt | 2 516 | 3 686 | 2 389 | 1 634 | 373 |
EBITDA margin
-120435000.0%
This company
15.8%
Market median
-762246935% vs market
20202024
Equity ratio
91.5%
This company
38.2%
Market median
+140% vs market
20202024
Return on equity
-12.2%
This company
18.4%
Market median
-166% vs market
20202024
Net profit margin
-49037000.0%
This company
8.1%
Market median
-605395162% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Deputy Member | Deputy Member | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2011 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JELSTAD SANDANGER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Astrid Jelstad | Deputy Member | 0 companies |
| Tore Liljedahl Sandanger | Chairman | 0 companies |